Skip to content

Het effect van een suikerbelasting op de vaatwand van de aorta.

Effects of postprandial hyperglycemia on aortic elasticity in impaired glucose tolerance and diabetes mellitus type 2.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24498
Enrollment
36
Registered
2010-07-08
Start date
2010-03-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus 2 (ouderdomssuikerziekte) Aortic elasticity (flexibiliteit van de aorta)

Interventions

Subjects will arrive after an overnight fast. A cannula will be inserted for blood drawing during the MRI scan. MRI scan will be performed to measure baseline cardiac function, abdominal waist fat and

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Impaired fasting glucose (fasting glucose 5.6-6.9 mmol/l); 2. Age 18-75 years; 3. Informed consent. Controls: 1. Subjects with normal fasting glucose matched for age (18-75), BMI, blood pressure and gender; 2. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Fasting plasma glucose =/. 7 mmol/l or previously diagnosed T2DM; 2. Grade 2 or 3 hypertension at screening according to ESC guidelines 2007; 3. Use of medication; antihypertensives, glucose lowering medication, statins of fibrates; 4. Any significant chronic disease; 5. Renal, hepatic or other endocrine disease; 6. Smoking; 7. Pregnancy; 8. Contra-indications MRI; 9. Recent participation in other research projects in one year.

Design outcomes

Primary

MeasureTime frame
1. Magnetic resonance imaging: Aortic pulse wave velocity; 2. Heart rate variability.

Secondary

MeasureTime frame
1. Heart dimensions: End-diastolic volume, end systolic volume, LV mass, LV mass index, LVMI/EDVI; 2. Heart function: Systolic function (stroke volume, ejection fraction, cardiac output, cardiac index, peak ejection rate), diastolic function (early peak filling rate E, early deceleration peak, atrial peak filling rate A, E/A ratio, peak mitral annulus longitudinal motion, MR estimate of LV filling pressure); 3. Body fat distribution; 4. Glucose and insulin levels.

Contacts

Public ContactN. Tjeerdema

Department Internal Medicine / Endocrinology, C4 70

n.tjeerdema@lumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)